ARYx Therapeutics
closedPharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.
Launch date
Employees
Market cap
CAD324k
Enterprise valuation
CAD324k (Public information from Sep 2024)
Share price
$0.0005 ARYX
Fremont California (HQ)
Authorizing premium user...